Income Statement (TTM)
NextCell Pharma AB Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 11-30 |
2021 02-28 |
2021 05-31 |
2021 08-31 |
2021 11-30 |
2022 02-28 |
2022 05-31 |
2022 08-31 |
2022 11-30 |
2023 02-28 |
2023 05-31 |
2023 08-31 |
2023 11-30 |
2024 02-29 |
2024 05-31 |
2024 08-31 |
2024 11-30 |
2025 02-28 |
2025 05-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 8 | 9 | 11 | 14 | 16 | 15 | 14 | 11 | 9 | 10 | 10 |
| Change (%) | -9.09 | 4.92 | 14.13 | 4.47 | 18.21 | 12.78 | 0.40 | 26.73 | 11.33 | 29.05 | 23.04 | 12.05 | -2.11 | -11.15 | -17.08 | -16.23 | 10.71 | -2.11 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 7 | 9 | 10 | 10 | 9 | 8 | 8 | 9 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 15 | 15 | 15 | 14 |
| Change (%) | 30.56 | 9.12 | -1.71 | -9.96 | -6.13 | -4.15 | 8.33 | 13.15 | -2.60 | 12.08 | 2.07 | 3.79 | -4.06 | -1.03 | 40.45 | -1.06 | -1.21 | -3.93 | |
| % of Revenue | 173.42 | 249.06 | 259.04 | 223.08 | 192.28 | 152.69 | 129.78 | 140.03 | 125.03 | 109.39 | 95.00 | 78.81 | 73.00 | 71.54 | 79.69 | 134.97 | 159.42 | 142.25 | 139.61 |
| Gross Operating Profit | -3 | -6 | -6 | -5 | -4 | -3 | -2 | -2 | -2 | -1 | 1 | 3 | 4 | 4 | 3 | -4 | -6 | -4 | -4 |
| Change (%) | 84.57 | 11.94 | -11.67 | -21.68 | -32.50 | -36.27 | 34.97 | -20.77 | -58.25 | -168.73 | 421.63 | 42.80 | 3.18 | -36.61 | -242.82 | 42.32 | -21.28 | -8.24 | |
| % of Revenue | -73.42 | -149.06 | -159.04 | -123.08 | -92.28 | -52.69 | -29.78 | -40.03 | -25.03 | -9.39 | 5.00 | 21.19 | 27.00 | 28.46 | 20.31 | -34.97 | -59.42 | -42.25 | -39.61 |
| SG&A | 16 | 17 | 18 | 19 | 21 | 24 | 28 | 32 | 35 | 38 | 41 | 43 | 46 | 45 | 41 | 38 | 34 | 33 | 34 |
| Change (%) | 8.93 | 5.46 | 2.69 | 12.06 | 15.71 | 16.52 | 11.86 | 9.49 | 7.70 | 8.69 | 6.48 | 5.44 | -2.52 | -8.63 | -6.39 | -10.81 | -3.78 | 3.09 | |
| % of Revenue | 390.38 | 467.76 | 470.15 | 423.00 | 453.75 | 444.17 | 458.94 | 511.35 | 441.80 | 427.40 | 359.96 | 311.51 | 293.11 | 291.88 | 300.16 | 338.84 | 360.75 | 313.54 | 330.19 |
| R&D | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| OpEx | 24 | 27 | 29 | 29 | 31 | 34 | 37 | 41 | 45 | 48 | 52 | 55 | 58 | 56 | 52 | 54 | 51 | 50 | 51 |
| Change (%) | 15.32 | 6.67 | 1.22 | 4.44 | 9.73 | 10.90 | 10.87 | 10.11 | 4.94 | 9.26 | 5.52 | 5.04 | -2.80 | -7.09 | 4.45 | -6.82 | -1.83 | 2.27 | |
| % of Revenue | 574.58 | 728.86 | 740.99 | 657.14 | 656.93 | 609.84 | 599.72 | 662.26 | 575.40 | 542.41 | 459.23 | 393.81 | 369.14 | 366.53 | 383.29 | 482.79 | 537.05 | 476.23 | 497.52 |
| Operating Income | -19 | -23 | -25 | -25 | -26 | -28 | -31 | -35 | -38 | -39 | -41 | -41 | -42 | -41 | -39 | -43 | -41 | -39 | -41 |
| Change (%) | 20.47 | 6.94 | -0.80 | 4.43 | 8.21 | 10.54 | 12.96 | 7.15 | 3.60 | 4.79 | 0.64 | 2.65 | -3.06 | -5.57 | 12.05 | -4.36 | -4.70 | 3.43 | |
| % of Revenue | -474.58 | -628.86 | -640.99 | -557.14 | -556.93 | -509.84 | -499.72 | -562.26 | -475.40 | -442.41 | -359.23 | -293.81 | -269.14 | -266.53 | -283.29 | -382.79 | -437.05 | -376.23 | -397.52 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -0.37 | -7.18 | 3.32 | 44.32 | 34.47 | 36.30 | -32.46 | -4.96 | -30.64 | -66.82 | -4.97 | -95.48 | 633.86 | 17.81 | 23.59 | 17.91 | -24.19 | -14.59 | |
| % of Revenue | -0.19 | -0.21 | -0.19 | -0.17 | -0.23 | -0.27 | -0.32 | -0.22 | -0.16 | -0.10 | -0.03 | -0.02 | -0.00 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Net Income | -19 | -23 | -25 | -25 | -26 | -28 | -30 | -35 | -37 | -38 | -40 | -40 | -41 | -39 | -37 | -42 | -40 | -38 | -40 |
| Change (%) | 20.28 | 6.96 | -1.60 | 4.07 | 8.08 | 10.32 | 13.41 | 7.08 | 3.23 | 4.21 | 0.01 | 2.20 | -3.23 | -5.32 | 12.56 | -4.18 | -4.71 | 3.78 | |
| % of Revenue | -474.02 | -627.16 | -639.35 | -551.21 | -549.09 | -502.04 | -491.08 | -554.72 | -468.70 | -434.63 | -350.97 | -285.28 | -260.20 | -257.21 | -274.10 | -372.04 | -425.55 | -366.27 | -388.33 |
Source: Capital IQ
